Johnson & Johnson (BVL:JNJ)

Peru flag Peru · Delayed Price · Currency is PEN · Price in USD
190.00
0.00 (0.00%)
At close: Nov 21, 2025
16.11%
Market Cap1.68T
Revenue (ttm)322.36B
Net Income (ttm)87.87B
Shares Outn/a
EPS (ttm)36.20
PE Ratio19.15
Forward PE18.37
Dividend18.30 (9.63%)
Ex-Dividend DateNov 25, 2025
Volumen/a
Average Volume0
Open190.00
Previous Close190.00
Day's Range190.00 - 190.00
52-Week Range141.90 - 190.00
Betan/a
RSI96.23
Earnings DateJan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange Lima Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.